Status:

COMPLETED

Continuing Access to Axitinib (A406- AG- 013736 ) For Patients Previously Receiving AG 013736 In Clinical Trials

Lead Sponsor:

Pfizer

Conditions:

Solid Tumors

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

To allow continuation of axitinib (AG 013736) treatment to patients experiencing clinical benefit in a closing axitinib trial

Detailed Description

This is a roll over study aimed to provide continued access to axitinib (monotherapy or combination, according to treatment received in prior axitinib study) to patients who have documented stable, or...

Eligibility Criteria

Inclusion

  • Patients who were assigned to an axitinib (AG-013736) containing treatment arm in a previous clinical trial
  • Patients who were receiving axitinib (AG-013736) tablets at the time their previous trial ended
  • Patients who have stable (SD) or responding disease (PR or CR) documented by the appropriate radiological, clinical, or laboratory assessments within 12 weeks before enrollment (Note: response criteria from the previous axitinib (AG-013736) protocol should be used to determine stable or responding disease).
  • Patients who have progressive disease (PD) but have experienced "clinical benefit" as defined in the study protocol

Exclusion

  • Patients may not participate in this trial if the conditions for continuing treatment in the previous axitinib (AG-013736) protocol are not met

Key Trial Info

Start Date :

March 7 2003

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

August 14 2023

Estimated Enrollment :

52 Patients enrolled

Trial Details

Trial ID

NCT00828919

Start Date

March 7 2003

End Date

August 14 2023

Last Update

December 3 2024

Active Locations (34)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 9 (34 locations)

1

UC Irvine Medical Center

Orange, California, United States, 92868

2

University of California Irvine Medical Center - Chao Family Comprehensive Cancer Center

Orange, California, United States, 92868

3

UCSF Helen Diller Family Comprehensive Cancer Center

San Francisco, California, United States, 94158

4

UCLA Hematology-Oncology-Santa Monica

Santa Monica, California, United States, 90404